Athenex to Provide Corporate and Financial Update for the Third Quarter 2021, on November 5, 2021

NEXT STORY
SCYNEXIS Pivotal Phase 3 VANISH-303 Trial Results Published in Clinical Infectious Diseases Demonstrate Significant Superiority of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
PREV STORY
Insights on the Polymerase Chain Reaction Consumables Global Market to 2027 – Growing Adoption of Technological Advancements Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cyclacel Pharmaceuticals to Release Second Quarter 2021 Financial Results and Provide Business Update

author_avatar
NASDAQ Market News

Clinical Trial Supplies Market Report 2021-2031

author_avatar
NASDAQ Market News

CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News